Search Results 141-150 of 11408 for ���������������������������:za33���24������ ������������������������ ������

  1. Clinical trials - Oncology (Medical)

    Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients ...

  2. Study Assessing Activity of Intravenous (IV) ABBV-383 Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-011889; Jacksonville, Florida: 24-011889. NCT ID: NCT06158841. Sponsor Protocol Number: M22-574. About this study. The purpose ...

  3. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

    ... 24:59-05:00</lastmod><xhtml:link rel="alternate" hreflang="en" href="https://www.mayoclinic.org/tests-procedures/cardiac-rehabilitation/multimedia/vid ...

  4. https://www.mayoclinic.org/chinese_organization_concepts.xml

    ... 24-05:00</lastmod><xhtml:link rel="alternate" hreflang="ar" href="https://www.mayoclinic.org/ar/departments-centers/cardiovascular-medicine/sections ...

  5. A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303) - Mayo Clinic

    Jacksonville, Florida: 24-004302; Rochester, Minnesota: 24-004302; Scottsdale/Phoenix, Arizona: 24-004302. NCT ID: NCT06259552. Sponsor Protocol Number: PROT-CR ...

  6. Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment - Mayo Clinic

    ... 24 hours[hrs]); OR - IgA, IgM, IgD, or IgE multiple myeloma (serum M-protein level >= 0.2 g/dL or urine M-protein level >= 200 mg/24 hrs); OR - Light chain ...

  7. Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) - Mayo Clinic

    ... 24-2 testing protocol;; Relative afferent pupillary defect (unless the contralateral eye had previous NAION or other optic nerve or retinal disease that is ...

  8. Zaleplon (oral route) - Mayo Clinic

    Zaleplon is used to treat insomnia (trouble sleeping). It belongs to the group of medicines called central nervous system (CNS) depressants, which slows down ...

  9. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  10. The Fourth Left Atrial Appendage Occlusion Study - Mayo Clinic

    Rochester, Minnesota: 24-005620; Scottsdale/Phoenix, Arizona: 24-005620. NCT ID: NCT05963698. About this study. The purpose of this study is to determine if ...